{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:50Z","timestamp":1740134870362,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,11]]},"DOI":"10.1182\/blood.2022016696","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T15:32:12Z","timestamp":1660231932000},"page":"528-529","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Glutamine and CLL: ready for prime time?"],"prefix":"10.1182","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-5036","authenticated-orcid":false,"given":"Silvia","family":"Deaglio","sequence":"first","affiliation":[{"name":"University of Turin"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"6","key":"2022081115315906300_B1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood.2021013990","article-title":"Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment","volume":"140","author":"Chen","year":"2022","journal-title":"Blood."},{"issue":"26","key":"2022081115315906300_B2","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1182\/blood-2014-02-554220","article-title":"Kinetics of CLL cells in tissues and blood during therapy with the BTK inhibitor ibrutinib","volume":"123","author":"Wodarz","year":"2014","journal-title":"Blood."},{"issue":"7","key":"2022081115315906300_B3","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-15-1965","article-title":"Disruption of in\u00a0vivo chronic lymphocytic leukemia tumor-microenvironment interactions by ibrutinib \u2013 findings from an investigator-initiated phase II study","volume":"22","author":"Niemann","year":"2016","journal-title":"Clin Cancer Res."},{"issue":"8","key":"2022081115315906300_B4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s43018-021-00216-6","article-title":"Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia","volume":"2","author":"Lu","year":"2021","journal-title":"Nat Cancer."},{"issue":"10","key":"2022081115315906300_B5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer."},{"issue":"13","key":"2022081115315906300_B6","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1182\/blood-2012-03-415737","article-title":"The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state","volume":"120","author":"Tili","year":"2012","journal-title":"Blood."},{"issue":"22","key":"2022081115315906300_B7","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"Jitschin","year":"2015","journal-title":"Blood."},{"issue":"10","key":"2022081115315906300_B8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.neo.2017.07.004","article-title":"The stromal microenvironment modulates mitochondrial oxidative phosphorylation in chronic lymphocytic leukemia cells","volume":"19","author":"Vangapandu","year":"2017","journal-title":"Neoplasia."},{"issue":"11","key":"2022081115315906300_B9","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/nm.4407","article-title":"Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis","volume":"23","author":"Romero","year":"2017","journal-title":"Nat Med."},{"issue":"11","key":"2022081115315906300_B10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1182\/blood-2015-01-621870","article-title":"Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition","volume":"126","author":"Jacque","year":"2015","journal-title":"Blood."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/6\/528\/1912866\/bloodbld2022016696c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/6\/528\/1912866\/bloodbld2022016696c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T15:32:24Z","timestamp":1660231944000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/6\/528\/486103\/Glutamine-and-CLL-ready-for-prime-time"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022016696","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2022,8,11]]}}}